CRON logo

Cronos Group Inc. (CRON)

$3.27

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CRON

Market cap

$1.20B

EPS

-0.02

P/E ratio

--

Price to sales

6.86

Dividend yield

--

Beta

0.966553

Price on CRON

Previous close

$3.38

Today's open

$3.36

Day's range

$3.25 - $3.37

52 week range

$2.28 - $3.91

Profile about CRON

CEO

Michael Gorenstein

Employees

356

Headquarters

Stayner, ON

Exchange

NASDAQ Global Market

Shares outstanding

366471299

Issue type

Common Stock

CRON industries and sectors

Healthcare

Pharmaceuticals

News on CRON

One Regulator Could Soon Unlock Altria And Cronos' Cannabis Fortune

Altria remains fundamentally well-positioned for U.S. cannabis entry, primarily through its 42% stake in Cronos Group. MO's core tobacco business continues to generate robust cash flow, with Q2 2026 adjusted EPS up 2.8% and a 4.7% dividend increase. Cronos delivered record Q3 results, maintains a strong balance sheet, and is expanding internationally, setting up for potential U.S. market entry.

news source

Seeking Alpha • Nov 9, 2026

news preview

Cronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript

Cronos Group Inc. (CRON:CA) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 7, 2026

news preview

Cronos Group Q3 Earnings Call Highlights

Cronos Group NASDAQ: CRON reported record third-quarter revenue, gross profit and adjusted EBITDA as cannabis sales grew in Israel, Canada and Germany, while executives outlined plans to expand in Europe following the company's acquisition of Dutch cannabis producer CanAdelaar.

news source

MarketBeat • Nov 5, 2026

news preview

Cronos Group Reports 2026 Third Quarter Results

Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count

news source

GlobeNewsWire • Nov 5, 2026

news preview

Cronos Group (CRON) Q3 Earnings and Revenues Beat Estimates

Cronos Group (CRON) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.07 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Are Medical Stocks Lagging Cronos Group (CRON) This Year?

Here is how Cronos Group (CRON) and Amgen (AMGN) have performed compared to their sector so far this year.

news source

Zacks Investment Research • Oct 26, 2026

news preview

Cronos (CRON) Upgraded to Strong Buy: Here's What You Should Know

Cronos (CRON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

news source

Zacks Investment Research • Oct 23, 2026

news preview

Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company

Cronos acquires CanAdelaar for a base purchase price of €57.5 million plus cash earnout of 0.5x Normalized EBITDA 1 in 2026 and 2027

news source

GlobeNewsWire • Oct 15, 2026

news preview

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1.

news source

GlobeNewsWire • Oct 13, 2026

news preview

CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?

Cronos Group stock climbs 17% in three months on strong revenue growth and margin gains, but rising competition and regulatory risks raise questions about its upside.

news source

Zacks Investment Research • Oct 9, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Cronos Group Inc.

Open an M1 investment account to buy and sell Cronos Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CRON on M1